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Abstract
Background: Published studies of the past decades have established that mass transfer 
across the dialyzer membrane is governed by diffusion, convection and osmosis. While the 
former is independent of the pressure in the liquids, the latter two are pressure dependent 
and are enhanced when the pressure difference across the membrane is increased. The 
goal of the present study is to examine the impact of pulsatile flow on the transport 
phenomena across the membrane of a high-flux dialyzer in a wearable artificial kidney 
(WAK) with a novel single small battery-operated pulsatile pump that drives both the 
blood and dialysate in a counter-phased manner, maximizing the trans-membrane 
pressure.
Methods: Both in-vitro experimental and numerical tools are employed to compare the 
performance of the pulsatile WAK dialyzer with a traditional design of a single-channel 
roller blood pump together with a centrifugal pump that drives the dialysate flow. The 
numerical methods utilize the axisymmetric Navier-Stokes and mass transfer equations to 
model the flow in the fibers of the dialyzer.
Results: While diffusion is still the dominating transport regime, the WAK pump enhances 
substantially the trans-membrane pressure and thus increases mass convection that might 
be as high as 30% of the overall transfer. This increase is obtained due to the design of the 
pulsatile WAK pump that increases ultrafiltration by increasing the trans-membrane 
pressure.
Conclusions: The experimental and numerical results revealed that when pumping at 
similar flow rates, a small battery-operated pulsatile pump provides clearances of urea and 
creatinine similar as or better than a large heavy AC-powered roller pump.
Background
The mechanisms of solute transport across dialyzer's membranes have been studied for
more than half a century. Historically, it appears that pioneers of dialytic therapy were well
aware of diffusive phenomena when they designed dialyzers based on counter-current
exchangers [1,2]. Later on, convection was realized to be a primary mechanism in ultrafil-
tration and 'solvent drag' phenomena [3-5]. The factors influencing solute transport across
semi-permeable membranes have been summarized by Ronco et al [6]. Blood flow rates
greatly affect the clearance of small solutes such as urea, but larger solutes are affected
mainly by ultrafiltration rates.
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The shortcomings of steady flow dialyzer, especially in promoting protein adsorption,
are well known and therefore time-dependent flow solutions have been suggested. Most
notably, the push/pull hemodiafiltration has been studied quite extensively. The effect of
pulsatile blood flow on the filtration rate of hollow fibers has been studied by various
researchers [4,7-9] while adsorption of proteins has been also considered, e.g. [10,11].
These studies indicate clinically interesting and effective blood purification outcomes
enhanced by convective solute removal and protein washout by the push-pull mecha-
nism. A push-pull hemodiafiltration (HDF) device provides rapidly alternating forward-
backward filtration [8,9]. This mechanism leads to alternate flow of body fluid and sterile
pyrogen-free dialysate across a high flux hollow-fiber membrane, enhancing overall per-
formance of the dialyzer. The main drawbacks of these push-pull HDF devices are the
necessity of a disposable blood reservoir bag to prevent flow variation, and the difficulty
in maintaining the trans-membrane pressure (TMP) that may lead to collapse of hollow
fibers during backfiltration. The remedy to these problems has been suggested to be the
use of volume controllers for ultrafiltrate removal and rigid synthetic hollow fibers such
as polyacrylonitrile, polysulfone, and polyamide [8,9].
The flow and mass transfer processes in dialyzers have been studied computationally
by employing either 1-D lumped models [e.g. [12]] or by solving the Navier-Stokes equa-
tions in 2-D or 3-D models e.g. [13-16], including models of hollow fibers and the sur-
rounding shell. However, in the multi-dimensional cases, only conventional steady flow
dialyzers have been modeled. Computational studies relevant to pulsating flow dialyzers
have not been published.
The wearable artificial kidney (WAK) developed in the past several years [17-21] is a
light-weight belt-type battery-operated device which utilizes the advantages of pulsatile
low flow rate of blood and dialysate (40-80 ml/min) to provide around-the-clock dialysis
treatment to patients with end-stage renal disease. The present study is aimed at explor-
ing the impact of pulsatile flow of low flow rate on the transport of small molecule sol-
utes in a high-flux dialyzer. Comparative experimental studies and numerical
simulations have been deployed to clarify and verify the role of parameters influencing
mass transport phenomena across the membrane of the WAK dialyzer with counter-
phased pulsatile flow. The results are compared with a conventional dialyzer. Since the
WAK is working around-the-clock, a significantly lower flow rate can be employed.
None of the previous experimental or computational studies have considered this regime
of parameters and operational modes.
Methods
Experimental Apparatus and Methods
The main pulsatile pump of the WAK uses a 3-Watt DC micro-motor (Faulhaber, Schoe-
naich, Germany). The mechanical assembly of the pump has been redesigned to accom-
modate an oscillating mechanism, which in conjunction with a custom-made dual-
ventricle flow cartridge allows counter-phased, simultaneous pulsatile flows of both
blood and dialysate at controllable rates of 40-80 ml/min, [17-21]. When one channel is
propelling fluid out of its compliant chamber (very much as in "systole"), the other one is
filling the compliant ventricle ("diastole"), creating a peak pressure in one channel at the
same time the pressure in the other channel is at its lowest level.
To compare the effect of pulsatile flow generated by the dual-ventricle pump, a roller
pump (Minipump™, MINNTECH renal systems, Minneapolis, MN), which is similar toRambod et al. BioMedical Engineering OnLine 2010, 9:21
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conventional hemodialysis machine blood pumps, is used to drive the blood flow, while a
centrifugal pump is employed to drive the dialysate flow. In both cases, Multiflow 60
AN69 HF hollow fiber dialyzer (Hospal Industrie, Meyzieu, France) is used.
The WAK pump measures 10 × 7 × 5 cm, weighs 380 gm and produces 95 ml/min
(peak 350 ml/min) each of blood and dialysate at 110 cycles/min and a stroke volume of
0.8 cm3. The Minipump measures 30 × 15 × 15 cm, weighs 4650 gm and produces 95 ml/
min (peak 120 ml/min) of blood at 13 cycles/min and a stroke volume of 8 cm3. The cen-
trifugal pump (Powerhead, Meiko, Taichung, Taiwan) measures 8 × 7 × 7 cm and weighs
65 gm. Additional details on the experiment setup used can be found in Ref. [20].
Two series of experiments are performed, one using the WAK pulsatile pump, the
other using the roller and centrifugal pumps combination. Figure 1 shows the conceptual
schematics of the test setup. While both the WAK and the roller pumps push blood into
the dialyzer, the dual-ventricle pump in the WAK pulls dialysate out of the dialyzer
whereas a centrifugal pump is used to pump the dialysate through the dialyzer in the sec-
ond setup. Either porcine blood or imitation blood (isotonic saline) are used. In the cases
with the porcine blood, approximately 5 liters of heparinized porcine blood are prepared
with a hematocrit of ~30%, following Protocol P00504 (Porcine Blood Handling), and it
is boosted with BUN and creatinine of about 60 and 10 mg/dL, respectively. The blood is
mixed gently every five minutes to keep it homogenous. In the beginning of the first
experiment, the blood is re-circulated for one minute through the primary reservoir to
ensure that all components of the system work properly without loss of blood. Following
this brief period of one minute, the blood line is altered in a way that mimics the return
of blood to the patient to maintain a reasonable trans-membrane pressure (TMP). The
initial concentrations of urea and creatinine in the reservoir are measured and recorded
at this point. Standard isotonic saline is used as the dialysate.
Both the blood and dialysate returns are located at levels of the respective reservoir
containers. Blood return is collected for use in roller pump experiments whereas
dialysate return is discarded. In some tests, dialysate return passed through powder-
filled canisters to generate an afterload that increases the pressure level at the blood out-
let. Ultrafiltration is drawn in some of the experiments. In addition, a pH meter elec-
trode is placed in the dialysate circuit at the exit site from the sorbent system and set to
Figure 1 A schematic description of the WAK experimental setup.
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trigger a sodium bicarbonate infusion to the dialysate prior to its entrance into the dia-
lyzer to maintain the pH of the dialysate in the dialyzer at approximately 7.4.
Flow rates and pressure are measured simultaneously at the inlets and outlets of the
dialyzer's compartments. Four ultrasonic flow meters and probes (Transonic Systems,
Ithaca, NY), and four pressure sensors (Merit Medical, South Jordan, UT) are employed,
see Figure. 1. A LabView virtual instrument (National Instruments, Austin, TX) is used
to record the flow and pressure. i-STAT Portable Clinical Analyzer (Abbott, East Wind-
sor, NJ) and corresponding cartridges are used for in-situ concentration measurement of
solutes in both the blood and dialysate flows. The i-STAT readings are subsequently cor-
roborated by an outside lab as the readings for dialysate are only qualitative. Each exper-
iment of WAK pump settings of 6.0, 7.5, 9.0 and 12 Volts is carried out for a 15 minutes
period. The mean flow rate for these settings is approximately 40, 50, 60 and 80 ml/s,
respectively. For each experiment, samples are drawn from the blood and dialysate exit-
ing the dialyzer in one and a half minute intervals. The concentrations of urea and crea-
tinine in these samples, 10 per experiment, are analyzed by an outside lab. The flow
conditions for the roller pump are adjusted to satisfy an approximately equal inflow
blood as with the WAK pump. Similarly, the flow conditions with the centrifugal pump
are adjusted to satisfy an approximately equal inflow saline as with the WAK pump.
The Numerical Model
The Multiflow M60 hemofilter consists of approximately 4400 AN69 hollow fibers with
an inner radius of 120 μm, a thickness of 50 μm and a length of 15 cm. The inner diame-
ter of the hemofilter is 33 mm. As a first approximation, the hollow fibers are assumed to
be distributed uniformly inside the hemofilter. The array of hollow fibers is represented
by a single hollow fiber, where the blood flows in one direction, and the surrounding
shell, where the dialysate flows in the counter direction. A further simplification assumes
that this basic unit is axisymmetric with an outer radius of 225 μm. Figure 2 illustrates
the domain used in the model. The flow in the shell is found to be non-uniform [15]. Yet,
since the aim of the present investigation is to quantify mass transfer processes, the pres-
ent simplifications of the geometry are reasonable. The domain of computation is com-
posed of three sub-domains (Figure 2), similar to previous numerical studies [14-16].
Two domains are free-flow domains: the blood flow in the hollow fiber and the dialysate
flow in the surrounding shell. The third sub-domain is the porous membrane domain.
Figure 2 The computational domain.
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The continuity equation is
where ρ is the mixture density and   is the velocity (in the membrane region, the
superficial velocity is used). The momentum conservation (Navier-Stokes) equation for a
laminar Newtonian flow is:
where P is the pressure, μ is the molecular viscosity and   is a source term that van-
ishes everywhere except in the porous membrane domain.
The membrane is modeled as a porous rigid medium using the Brinkman approxima-
tion, [22]. The radial momentum source term is composed of two parts: a viscous
(Darcy) loss term and a term rising from the osmotic pressure:
where v is the radial velocity component, k is the permeability and π is the osmotic
pressure. The osmotic pressure is mainly produced by proteins. For small molecule sol-
utes, as considered in the present study, the osmotic pressure is negligible. Neglecting
the inertial and viscous terms in the membrane region, the radial momentum equation
can be integrated to yield
The difference (Δ) is taken between the two membrane surfaces (with the same axial
coordinate), h is the thickness of the membrane (h = R2 - R1 = 50 μm) and Lp is the
hydraulic permeability. This approximation of the radial momentum equation, also
known as the Starling's law of filtration, is widely used in studies of membrane filtration
[22]. It should be noted however, that equation (4) does not take into account diffusion
or unsteady effects, while the Brinkman approximation, employed in the present study,
does account for these contributions.
The mass transport of solute i is given by
where Ci and Di are the concentration and the diffusion coefficient of solute i in the
mixture, respectively. In the free-flow domains, the retardation coefficient is λ = 1, while
in the membrane region λ = 1 - σ, where σ is known as the reflection coefficient. It is a
phenomenological parameter that characterizes the hindrance of convective transport
across the membrane; for small molecule solutes, as considered in the present study, σ =
1 is assumed.
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Referring to Figure 2, the following boundary conditions are employed. At the inlet the
velocity and mass-fraction ratio are specified
where u and v are the axial and radial velocity component, respectively.Ci,B and Ci,S are
the concentration of solute i at the blood and dialysate inlets, respectively. Due to the low
Reynolds number of the flow, a fully developed flow is assumed both at the blood and
dialysate inlets. At the outlet, the pressure is satisfied:
where PB0(t) and PS0(t) are the outlet pressure of the blood and dialysate domains,
respectively. The value of the inlet velocity and outlet pressure waveforms are specified
from the experimental measurements. Outflow conditions are specified for the mass-
fraction ratio.
The domain of solution is meshed by Gambit (Ansys, Inc.) using quadrilateral cells
with clustering near solid walls and near the membrane edges. A total of over 30,000
cells are employed based on a mesh-independence test. The solution of the finite-volume
discrete equations is performed using Fluent (Ansys, Inc.). A second-order accurate
scheme is used with the SIMPLE approach for decoupling the pressure.
Physical Properties and Non-Dimensional Numbers
In the experimental investigations, imitation blood/isotonic saline is used as well as hep-
arinized porcine blood. In the numerical simulations, a Newtonian aqueous solution
(isotonic saline) is defined with density of ρ = 1000 kg/m3 and constant viscosity of μ =
0.001 kg/m sec. In the dialysate, plasma is assumed to flow with the same properties. The
mass diffusion coefficient in the blood and dialysate sides is assumed to be identical. The
value of the mass transfer coefficient for each solute as well as the permeability are esti-
mated from the experimental results as elaborated in the Results section.
Three non-dimensional numbers govern the flow and mass transfer processes in the
model of the hollow fiber: the Reynolds (Re), Peclet (Pe) and the Womersley (α) num-
bers. These non-dimensional numbers are evaluated separately for the free flow domains
and for the porous membrane domain. In the free flow domains, the Reynolds number
( , where d is a reference length) is based on d = 2 R1 or R3 - R2 for the blood or
dialysate domains, respectively, and u is a mean velocity. The Womersley number is
given by  , where f is the frequency of the inflow waveform; is the kinematic
viscosity or the appropriate mass transfer coefficient. The Peclet number for solute i is
calculated from:  . In the porous membrane, the Peclet number can be esti-
mated from:  , where, v is the radial velocity component, UF is the
ultrafiltration rate, A is the total surface (0.6 m2) of the hollow fibers and Di,m is the effec-
tive mass diffusivity of solute i in the membrane.
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Table 1 presents separately for the free-flow and for the membrane domains the non-
dimensional numbers for a flow rate of 100 ml/min and an ultrafiltration rate of 20 ml/
min. These values correspond to the upper limits existing in the WAK. The mass diffu-
sivity is assumed to be 10-9 and 10-10m2/s in the free flow and membrane domains,
respectively. The frequency of the WAK pump (delivering both the blood and the
dialysate in counter-phased flows) is taken to be 2 Hz.
The Reynolds number is small in the fiber lumen (Re = 0.5) and negligible in the mem-
brane, justifying the Brinkman approximation. The Peclet number is large in the free
flow domains (Pe = 1200), indicating the dominance of mass convection in the blood and
dialysate domains. However, in the membrane region, the mass transfer is dominantly
viscous (Pe = 0.16). The Womersley number, that estimates the ratio of unsteady to diffu-
sion terms, is relatively small (α = 0.4), indicating a quasi-steady flow. In the membrane
region, the Womersley number is negligible, i.e., unsteady effects are negligible. The
Womersley number related to the mass transfer processes is large, especially in the blood
and membrane domains (α = 22 and 15, respectively). These large values correspond to a
saturated flow, i.e. the mass transfer processes are actually steady (except in a very thin
Stokes-like layer). Therefore, although the WAK pump induces time-dependent flow, the
flow and mass transfer processes are quasi-steady and the performance of the dialyzer
can be represented by the mean flow.
Results
A large number of experimental cases have been considered differing in the pump types,
blood and dialysate flow rates, ultrafiltration rate and the afterload. Table 2 summarizes
the relevant experimental results. The flow and mass transfer processes are quasi-steady
and therefore the mean of the inlet and outlet pressures and flow rates have been calcu-
lated from the time-dependent experimental results. The TMP is calculated using the
approximation
where Pb and Pd are the mean blood and dialysate pressure and in and out refer to the
inflow and outflow, respectively. The ultrafiltration coefficient KUF is calculated from:
where UF is the ultrafiltration rate.
Cases 1-7 present the results obtained for the roller pump with the four canisters in
place (i.e. with an afterload), while cases 15-25 refer to the roller pump cases, but with
TMP
Pbi n Pbo u t Pdi n Pdo u t =
+− + ( ,, )( ,, )
,
2
(8)
K
UF
TMP
UF = (9)
Table 1: The non-dimensional numbers (Mom. = momentum equation, mass = mass 
transfer equation)
α
Re Pe Mom. Mass
Free-flow 0.50 1200 0.43 22
Membrane 0 0.16 0.06 15R
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Table 2: Summary of the mean operating conditions of the experimental cases (P(mmHg), Q(ml/min), UF(ml/min), KUF(ml/hr/mmHg))
Case Pb,in Pb,out Pd,in Pd,out Qb,in Qb,out Qd,in Qd,ou TMP UF KUF
Roller pump for blood, centrifugal pump for dialysate, with afterload
1 108 100 166 172 83 100 45 28 -65 -17 16.0
2 71 63 158 162 49 76 54 26 -93 -28 18.0
3 58 50 112 116 46 65 38 18 -60 -20 20.0
4 4 03 38 88 92 84 93 31 4- 5 2 - 2 0 2 3 . 0
5 136. 127 167 173 100 118 45 26 -39. -18 28.0
6 162. 152 171 177 121 132 38 27 -17 -10 36.0
7 188 180 177 183 142 144 31 28 4 -3 -40.0
Roller pump for blood, centrifugal pump for dialysate, without afterload
15 62 57 17 9 82 71 42 53 47 11 14.0
16 27 23 8 2 40 39 43 44 20 2 4.5
17 17 14 -1 -9 28 26 31 33 21 2 4.9
18 13 10 -4 -12 20 19 24 26 20 2 5.3
21 62 55 22 20 82 72 50 59 38 10 15.0
22 44 37 9 9 65 58 40 47 32 7 13.0
23 32 27 3 2 52 45 34 40 27 6 14.0
24 22 19 -6 -8 42 36 20 26 28 6 14.0
25 11 8 -13 -14 23 19 9 13 23 4 10.0
WAK pump for both blood and dialysate, with afterload
31 39 33 -25 -32 77 51 42 65 64 24 23
32 24 21 -24 -31 50 34 38 56 50 17 20
33 19 16 -21 -29 37 25 33 44 42 12 16
34 6 5 -19 -25 10 4 30 35 27 5.5 12
35 22 18 -22 -30 43 29 36 50 46 14 18R
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WAK pump for both blood and dialysate, without afterload, porcine blood
41 31 30 13 10 37 39 40 38 19 -2 -6
44 33 34 10 5 46 48 60 58 26 -2 -5
47 43 43 12 7 57 56 56 57 34 1 2
50 51 45 7 -1 81 81 112 112 45 0 0
Roller pump for blood, centrifugal pump for dialysate, without afterload, porcine blood
53 34 32 24 20 44 46 51 49 11 -2 -13
56 36 35 26 24 51 54 67 64 11 -3 -15
59 39 36 27 25 60 62 79 77 12 -2 -12
62 55 48 34 27 82 84 112 110 21 -2 -7
Table 2: Summary of the mean operating conditions of the experimental cases (P(mmHg), Q(ml/min), UF(ml/min), KUF(ml/hr/mmHg)) (Continued)Rambod et al. BioMedical Engineering OnLine 2010, 9:21
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the canisters removed (i.e. without an afterload) and cases 31-35 employ the WAK pump
with an afterload as well. These experiments are conducted using imitation blood, while
in cases 41 through 62 porcine blood is used and no afterload is applied. It should be
noted that in the roller pump experiments with the canisters in place, a significant back-
filtration (negative ultrafiltration) is obtained. This is because the single roller pump
pumps the dialysate into the dialyzer while the WAK pump pulls the dialysate out of the
dialyzer, thus creating suction in the dialysate compartment. This suction effect
increases the pressure difference between the blood and dialysate compartments and
thus, enhances the convective mass transport.
The presentation of the results is divided into two parts, (i) ultrafiltration and (ii) clear-
ance results.
Ultrafiltration Characteristics
Figures 3 and 4 present sample experimental results for the two different pump setups
used in the experiments, the roller pump and the WAK pump setups (cases 23 and 32 in
Table 2), respectively. These cases are selected to have similar inflow rates. In each case,
the pressures and flow rates at the inlet and outlet of the blood and dialysate compart-
ments are shown, together with the ultrafiltration rate. The roller pump yields a quasi-
steady flow, while the WAK pump generates an inherently time dependent flow. In the
latter case, the pressure waveforms for the blood and dialysate compartments are in 180°
Figure 3 Experimental measurements of the inlet and outlet (a) pressures and (b) flow rates for the 
roller pump with no afterload (case 23 in Table 2).
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phase due to the novel design of the WAK pump. Similar results have been obtained for
other operating conditions of the two setups.
Figure 5 depicts the dependence of the ultrafiltration rate on TMP. Each one of the
above mentioned case-categories is marked by a different symbol: circles for the roller
pump experiments with the afterload, squares for the roller pump experiments without
afterload and the diamonds for the WAK pump experiments with afterload. Although
the mean blood and dialysate flow rates vary from case to case (Table 2), Figure 5 reveals
that the ultrafiltration rate depends mainly on the TMP. However, the dependence is
nonlinear, contrary to present practices that assume a linear relationship, [22]. This is
revealed by the best fit to a second-order polynomial of the roller-pump experimental
data points and separately for the WAK pump experiments. The slopes obtained for the
WAK pump are larger than that for the roller pump, but not by a significant margin. For
t h e  s a k e s  o f  b r evi t y ,  w e  r e f r a i n  fr o m  d i s p la yi n g  s e pa r a t e  f i ts  t o  t h e  da t a  po i n ts  a n d
instead we are presenting a good correlation (R2 = 0.995) to a second-order polynomial
for the entire range of results, see the solid line in Figure 5.
Figure 5 also presents UF vs. TMP as published in the spec-sheet of Gambro's M60
[23] for two blood inflow rates relevant to the WAK operation (55 and 38 ml/min, see
hollow squares and hollow circles, respectively). The agreement between the present
Figure 4 Experimental measurements of the inlet and outlet (a) pressures and (b) flow rates for the 
WAK pump (case 32 in Table 2).
 
 
 
 Rambod et al. BioMedical Engineering OnLine 2010, 9:21
http://www.biomedical-engineering-online.com/content/9/1/21
Page 12 of 22
experiments and Gambro's data is reasonable, but one has to note that the latter is
obtained for bovine blood, while the present results refer to blood analogous liquid with
vanishing osmotic pressure. The UF rate for aqueous solution should be larger by as
much as 15% [14,16]. On the other hand, the actual UF data are worse than published by
the manufacturers by about the same percentage [16], resulting in the good agreement.
The dependence of the ultrafiltration coefficient on the TMP is shown in Figure 6. For
positive TMP (pressure in the blood is larger than in the dialysate), the ultrafiltration
coefficient increases with TMP, although the increase rate slows down as the TMP
increases. The asymmetry in the KUF for positive and negative TMP is very clear. Com-
mon practices assume that KUF is constant, independent of the TMP. This is indeed
observed in the Gambro data of the M60 dialyzer (that is also shown in Figure 5) for the
higher TMP range [23]. The M60 dialyzer of Gambro yields an ultrafiltration coefficient
in the range of 16-22 ml/hr/mmHg for bovine blood, depending on the blood flow rate.
However, for the lower range relevant to the present study (TMP < 40 mmHg), the Gam-
bro data shows as well a dependence of the ultrafiltration rate on TMP. The Filtral 6 dia-
lyzer-spec provides a KUF value of 13-17 ml/hr/mmHg for bovine blood, [23]. The
present experiments results in a KUF in the range of 5 to 30 ml/hr/mmHg, depending on
the TMP and its sign.
Figure 5 The dependence of the ultrafiltration flow rate on the trans-membrane pressure (experimen-
tal results). The solid red line shows the best-fit to second order polynomial for the entire range of results. The 
manufacturer's results for the M60 dialyzer at 55 ml/min and 38 ml/min using bovine blood are also presented 
up to TMP = 100 mmHg.
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Comparison with Numerical Simulations and Estimation of the Hydraulic Permeability
A set of numerical simulations have been performed, a simulation for every one of the
cases of Table 2. The aim is to estimate the hydraulic permeability based on the experi-
mental data. Common practices assume that the hydraulic permeability of a given dia-
lyzer is constant, independent of the flow or pressure conditions. In the analysis of the
experimental results, such an assumption has not been made and the hydraulic permea-
bility, Lp, (Eq. 4) is determined separately for each one of the experimental cases. For
each one of the cases, Lp (translated to porous resistance) was varied until the calculated
UF rate was equal to the experimental value.
The calculated pressure variations and ultrafiltration velocity along the hollow fiber
and along the dialysate are shown in Figure 7 for the two cases that have been already
considered in Figures 3 and 4. The pressure distribution in the hollow fiber (blood side)
is reasonably similar in both cases. However, in the dialysate compartment, large nega-
tive gauge pressure is created by the WAK pump whereas in the roller pump case, a small
positive pressure is established. This difference generates a TMP twofold larger than in
the roller pump case, with a similar increase in the ultrafiltration velocity. Consequently,
Figure 6 The dependence of the ultrafiltration coefficient on the trans-membrane pressure (experi-
mental results). Note that when roller pump is used with afterload, significant backfiltration (negative ultrafil-
tration) is obtained and thus, the TMP is negative whereas in other cases, the TMP is positive showing maximum 
values when the WAK pump is used.
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the contribution of convection to the overall clearance of solutes increases substantially
when the WAK pump is used.
Based on the calculated inlet pressure and the imposed outlet pressure, the TMP is cal-
culated for all the numerical cases as well and the results are compared in Figure 8 with
the experimental values. The line marking a perfect match is also shown. The numerical
results over-predicted the roller pump TMP by 3-6 mmHg. The agreement with the
W AK pump experiments is excellent with a deviation of less than 1.5 mmHg. These
small deviations can be attributed to experimental errors that are estimated to be ±5-10
mmHg as well as to pressure losses at the entrance and exit of the dialyzer . Pressure
losses due to the non-uniform arrangement of the fibers in the dialyzer have not been
accounted for in the present numerical model.
The ultrafiltration rate can be calculated from the TMP using the Starling's law with-
out osmotic pressure effects (since no proteins are present): UF =LpA·TMP, where A is
the total fiber, yielding,
Figure 9 depicts the relationship between the calculated Lp and the KUF as found from
equation (9) using the experimental values of the ultrafiltration rate and TMP, together
with the line that plots the relationship (10) (marked as "Theory"). A significant devia-
tion from the theoretical value is obtained only for ultrafiltration coefficients higher than
25 ml/hr/mmHg for the roller pump case with an afterload, when significant backfiltra-
tion is obtained. However, for KUF relevant to the WAK operation, the Starling's law
describes accurately the linear relationship between the ultrafiltration rate and the
hydraulic permeability.
KL A UF p = . (10)
Figure 7 The pressure and ultrafiltration velocity distribution along the blood and dialysate compart-
ments of the dialyzer's membrane (computational results). The TMP induced by the WAK pump is about 
twice of the roller pump and so is the ultrafiltration velocity.
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Clearance Results
The concentrations of urea, creatinine and other solutes are measured experimentally at
the inlet and exit of both the blood and dialysate compartments. Table 3 summarizes the
measured concentration of BUN (representing urea) and creatinine for selected roller
pump and the WAK pump setups.
The mass diffusion coefficient of each solute in the blood, dialysate and membrane
regions is determined based on the results of case 23. In the cases elaborated in Table 3,
imitation blood is used and therefore it is reasonable to assume that the mass diffusion
coefficients of the aqueous blood and the dialysate are identical. The blood and dialysate
mass transfer coefficients of the free-flow and membrane flow are varied (separately for
urea and creatinine), within the range of values found in the literature, until the calcu-
lated exit concentration of both the blood and dialysate matches the experimental
results. An excellent match has been obtained for a mass transfer coefficient of D =
1.5·10-9 m2/s and 1.3·10-9 m2/s for urea and creatinine in the free-flow regions, and D =
1.3·10-10 m2/s and 1·10-10 m2/s in the membrane regions, respectively. These values of the
mass transfer coefficients are used in the numerical simulations of the other cases. In
vitro results by Sakai [24] using water found mass transfer coefficient of D = 1.8·10-9 m2/s
and 1.3·10-9 m2/s for urea and creatinine, respectively. Cussler [25] cites the value of
1.38·10-9 m2/s for urea in aqueous solution. The corresponding mass transfer coefficients
for blood are found in vivo to be D = 1.4·10-9 m2/s and 0.83·10-9 m2/s, respectively.
The distributions of the calculated urea concentration, C, relative to the inlet concen-
tration (C0) along the two sides of the membrane are shown in Figure 10 for cases 23
Figure 8 Comparison of the calculated and the experimental TMP.
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(roller pump) and 32 (WAK pump). The distributions of the pressure and ultrafiltration
velocity for these cases have been presented in Figure 7. Obviously, the setup with the
WAK pump (case 32) shows a better clearance of the urea. The reason is attributed to the
higher ultrafiltration rate obtained with the WAK pump. This higher ultrafiltration rate
increases the convective mass transfer flux, as presented in Figure 11. In the entrance to
the hollow fiber, the convective mass ratio is as high as 45% and 30% of the total mass
transfer for the WAK and roller pump cases, respectively, while at the exit, the ratio
decreases to 15% and 5%, respectively. In the WAK pump case, the overall convective
urea transfer ratio is 31% of the total urea transfer, while in the roller pump case it is 17%
only.
The ultrafiltration rate in the WAK cases is large relative to the blood flow rate (30-
50%) and therefore the conventional definition of the clearance is inappropriate. In these
cases, we suggest to define clearance by
where QB is the blood volumetric flow rate CB and is the concentration of the solute in
the blood. In the case of low ultrafiltration rate QB,in ≈ QB,out and the definition (11) is
K
QBi n CBi n QBo u t CBo u t
CBi n
=
− ,, , ,
,
, (11)
Figure 9 The dependence of the hydraulic permeability on the ultrafiltration coefficient KUF.
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identical to the conventional definition of clearance. The clearance results for both the
experiments and the numerical simulations are summarized in Table 4. The agreement
between the experimental and the numerical results is good for the roller pump and rea-
sonable for the WAK pump. The calculated errors between the experimental and numer-
ical results are within the expected range given that the experimental procedures suffer
from various measuring error sources of the flow rate, pressure and concentrations.
These estimated error values are 7-10%, 10-15% and 5-7%, respectively. Please note that
in the low flow rate cases, the flow and pressure measurements are noisier than in the
higher flow rates and thus, the errors are higher for the low flow.
The experimental urea clearances versus the TMP using the WAK and roller/centrifu-
gal pumps are plotted in Figure 12 irrespective of the other parameters (such as flow
rates). The creatinine clearance shows a very similar trend. Obviously, the WAK setup
yields similar or better clearance than the roller pump setup. The apparently only excep-
tion is the roller pump case using porcine blood without afterload (cases 53-62). How-
ever, a closer look reveals that the better clearance is obtained because of the increased
dialysate flow rate by as much as a factor of two in these cases, see Table 2.
Discussion
The experimental and numerical investigations of this study have shown the impact of
pulsatile flow in transport of solutes in a high-flux dialyzer. The parameters influencing
the transport phenomena across the dialyzer membrane in counter-phased pulsatile flow
in the blood and dialysate compartments are studied. The findings support the historical
belief of dialytic-therapy pioneers who designed dialyzers based on counter-current
exchangers [1,2] to exploit diffusive mass transport phenomena of small molecules.
However, the present study also reveals the relative contribution of ultrafiltration in to
Table 3: Summary of the urea and creatinine concentrations at the inlet and exit as 
obtained from experiments. Roller pump without afterload is used in cases 21-25 and the 
WAK pump (with afterload) is used in cases 31, 32 and 35
BUN (mg/dL) Creatinine (mg/dL)
Blood Dialysate Blood Dialysate
Inlet (mg/dL) 118 0 4.5 0
Case 21 73 95 3.0 3.1
Case 22 68 95 2.7 3.1
Case 23 56 88 2.3 2.9
Case 24 60 100 2.4 3.5
Case 25 61 99 2.4 3.6
Inlet (mg/dL) 38 0 6.8 0
Case 31 24 31 4.9 5.1
Case 32 8 21 2.1 3.5
Case 35 4 18 0.7 3.2Rambod et al. BioMedical Engineering OnLine 2010, 9:21
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enhanced clearance performance. These findings corroborate with other researchers'
findings on the advantages of 'solvent drag' and push-pull mechanisms [3-8]. These latter
studies point to the effect of pulsatile blood flow on the filtration rate of hollow fibers
[4,7,8] and adsorption of proteins on these hollow fibers [9-13]. The indicated effective
blood purification is believed to result from convective solute removal and protein wash-
out by the push-pull mechanism. A push-pull hemodiafiltration (HDF) device provides
rapid forward-backward filtration alternately [8,9], leading to alternate flow of body fluid
and sterile pyrogen-free dialysate across a high flux hollow-fiber membrane. These con-
ventional push-pull HDF devices, however, need a disposable blood-volume-control bag
and can have dangerously high trans-membrane pressures (TMP). These potentially
unsafe conditions can be avoided by using ultrafiltrate volume controllers and rigid syn-
thetic hollow fibers such as polyacrylonitrile, polysulfone, and polyamide [8,9].
The present study has shown experimentally that these hazardous conditions do not
exist in the WAK system. The TMP's are always within safe ranges of hollow-fiber
mechanical strength and there is no need for blood volume control. Furthermore, our
studies have produced reliable information on flow/pressure behavior of blood and
Figure 10 Comparison of the distribution of the relative urea concentration along the two edges of the 
membrane for the roller pump versus the WAK pump (computational results. The use of the WAK pump 
resulted in approximately 20% more urea removal than the roller pump.
 
 
Case 23 
 
 
Case 32 
Roller pump 
WAK pump Rambod et al. BioMedical Engineering OnLine 2010, 9:21
http://www.biomedical-engineering-online.com/content/9/1/21
Page 19 of 22
dialysate passing through relevant dialyzer compartments, as well as information on
clearance of urea and creatinine, for both the WAK pump and the roller/centrifugal
pump pair, delivering blood and dialysate at comparable flow.
The impact of afterload generated by a set of powder-filled canisters on the ultrafiltra-
tion was thoroughly studied and compared with the same system without the afterload
(no canisters). The results have shown that when the WAK pump was used, the counter-
phased blood and dialysate flows created twice as much pressure difference across the
membrane than that of the roller-centrifugal pumps (Figure 9). The results summarized
in Table 1 and depicted in Figure 7 have indicated that the trans-membrane pressure is
increased with the ultrafiltration rate. However, this relationship was not found to be lin-
ear but rather corresponds with a second-order polynomial function. The numerical
model re-established the linear relationship between the hydraulic permeability and the
ultrafiltration coefficient.
One of the major findings of the present study has been attributed to the efficiency of
the WAK pump in removing urea from blood. Figure 12 depicted better clearance of
urea when the WAK pump was used as oppose to conventional roller pump designs. The
reason for this phenomenon is attributed to the higher ultrafiltration rate obtained with
the WAK pump. This higher ultrafiltration rate caused by the higher TMP increases the
convective mass transfer flux along the length of the fiber. With the WAK pump, the
convective urea transfer is 31% of the total urea transfer, while with the roller pump that
value is only 17%.
Conclusions
It has been shown that the small, light-weight, battery-operated WAK pump yields the
same or slightly better clearances of urea and creatinine as the large, heavy, AC power-
requiring roller pump. Therefore, the dual-channel pulsatile pump is the most suitable
Figure 11 The distribution of the ratio of the convective urea transfer to the total urea transfer along 
the membrane for the two sample cases 23 (roller pump) and 35 (WAK pump).
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Table 4: Comparison of the experimental and calculated clearance data for urea and 
creatinine
Urea Clearance (ml/min) Creatinine Clearance (ml/min)
Case # Exp. Num. Err (%) Exp. Num. Err (%)
21 37 40 -8 24 26 -8
22 31 34 -9 21 22 -5
23 30 30 0* 20 20 0*
24 24 24 0 16 16 0
25 13 12 8 9 8 11
31 44 48 -8 28 32 -13
32 43 37 14 28 25 11
35 40 34 15 28 22 21
41 25 29 -14 16 18 -11
44 32 35 -9 21 22 -5
47 39 40 -3 24 25 -4
50 52 51 2 31 30 3
53 28 32 -13 19 21 -10
56 35 33 6 22 20 9
59 40 41 -2 25 24 4
62 52 50 4 31 30 3
*The mass transfer coefficients have been determined from this case
Figure 12 The dependence of the urea clearance on TMP for the WAK and roller pump setups, irrespec-
tive of other parameters.
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configuration for use in conjunction with the wearable artificial kidney while saving
energy and delivering adequate blood and dialysate flows for around-the-clock dialysis.
To further expand these findings, additional studies are required to determine the effi-
ciency of the WAK pump in removing other solutes such as phosphor, potassium, cal-
cium, beta-2-microglobulin or Para-cresol. Moreover, some of the computational model
assumptions, such as axisymmetry and uniform inlet flow conditions into the fibers
should be relaxed.
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